Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
August 1, 2024

IDDF2024-ABS-0318 Ligusticum cycloprolactam (LIGc), a novel FXR agonist: target activation of FXR ameliorate metabolic associated fatty liver disease

View Full Paper
Ask AI
Bookmark
Share

Authors

YYYongqi YangXDXin DingTLTian Lan

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yang et al. (2024) studied this question.

synapsesocial.com/papers/68e5e1dbb6db643587576808https://doi.org/10.1136/gutjnl-2024-iddf.38
View Full Paper
Ask AI
Bookmark
Share